H-Nva-OtBu · HCl is a protected amino acid derivative in which the amino group is presented as a free primary amine (H-N-) and the carboxyl functionality is masked as a tert-butyl ester (-COOtBu), with the side chain corresponding to norvaline (Nva). The molecule is provided as a hydrochloride salt, pairing HCl with the basic amine to form an ammonium chloride, which affects salt-state handling while retaining the tert-butyl ester as the key structural modification. In synthesis and analytical workflows, this salt-form, ester-protected norvaline derivative is used as a building block for preparing more complex amino acid and peptide intermediates, including stepwise assembly where the ester and salt-state can be used to manage chemoselectivity and reactivity of the functional groups.
CAT No: CP26238
CAS No:119483-47-5
Synonyms/Alias:L-Norvalinet-butylesterhydrochloride;119483-47-5;L-Norvalinet-butylesterHCl;L-Norvalinet-butylesterHCl;L-Norvalinetert-butylesterhydrochloride;H-Nva-OtBu.HCl;PubChem5693;SCHEMBL311215;CTK6C9873;MolPort-002-041-528;ANW-42015;CN-603;SBB070466;AKOS015913913;AK-44931;RT-013534;L-NORVALINET-BUTYLESTERHYDROCHLORIDE;ST24047477;M-2747;tert-butyl(2S)-2-aminopentanoatehydrochloride;I14-4462;J-300355;3B3-033574
H-Nva-OtBu · HCl is an N-aminated norvaline derivative presented as the hydrochloride salt, featuring a stereogenic α-carbon characteristic of the norvaline backbone and a protected carboxyl functionality as a tert-butyl ester. The molecule bears a free amino group as the hydrochloride-associated salt, enabling controlled participation in peptide coupling while maintaining handling stability during synthesis. The tert-butyl ester can be selectively deprotected under acid conditions to regenerate the carboxylic acid for subsequent amide bond formation or further functionalization. The combination of chiral amino acid structure, salt-form amino reactivity, and acid-labile ester protection makes it a practical chiral intermediate for protected amino acid synthesis and downstream peptide building block preparation.
1. Protected Amino Acids
H-Nva-OtBu · HCl is applied in protected amino acid chemistry where a Boc-like or tert-butyl ester protection strategy is used to manage orthogonal reactivity during synthesis. The tert-butyl ester protects the carboxylate while the hydrochloride-associated amine remains available for coupling chemistry after base-mediated salt neutralization. The norvaline side chain provides an aliphatic handle for constructing peptides with defined hydrophobic spacing and for generating derivatives that retain stereochemical integrity at the α-center. The acid-labile ester functionality supports staged deprotection to access the free carboxylic acid, enabling iterative assembly of amino acid derivatives and preparation of peptide building blocks for fine chemical synthesis.
2. Peptide Synthesis
H-Nva-OtBu · HCl is suitable for peptide coupling workflows in peptide synthesis, including stepwise solid-phase or solution-phase assembly. The protected amino acid format aligns with standard amide bond formation logic: the carboxyl group can be activated after deprotection, while the amino functionality can participate as the nucleophilic partner once salt form is appropriately managed. The chiral norvaline core contributes stereochemical control to peptide sequences, supporting the construction of analogs where side-chain length and hydrophobic character influence conformational preferences. The tert-butyl ester strategy also supports manufacturing-friendly intermediate handling, allowing downstream conversion into Nva-containing peptide fragments and enabling scalable preparation of peptide standards.
3. Side-Chain Functionalization
H-Nva-OtBu · HCl supports side-chain functionalization and amino acid derivatization programs that require a protected carboxyl group during chemical modification. The norvaline side chain is an aliphatic chain that can be carried through protection/deprotection cycles, enabling late-stage transformations such as oxidation, halogenation, or incorporation into functionalized scaffolds after the ester is converted to the corresponding acid or activated derivative. The hydrochloride salt form helps maintain amine protonation during handling, which can improve reproducibility when generating derivatives for subsequent coupling steps. The resulting functionalized amino acid intermediates can be used to generate peptidomimetic motifs, SAR-focused analog libraries, and downstream conjugation-ready fragments while preserving the stereogenic center.
4. Chiral Intermediate Synthesis
H-Nva-OtBu · HCl is used as a chiral amino acid intermediate in asymmetric synthesis planning and stereodefined building block preparation. The α-stereocenter inherent to the norvaline backbone allows downstream products to inherit stereochemical information without racemization during protected-stage manipulations. The tert-butyl ester provides a controllable carboxyl protection state that can be removed to reveal the acid for activation, salt formation, or conversion to acyl derivatives. The combination of chiral center fidelity and orthogonal functional group management supports process chemistry intermediate preparation, including the synthesis of Nva-containing fragments for peptide analog construction and stereochemically defined specialty chemicals.
5. Pharmaceutical Manufacturing Intermediates
H-Nva-OtBu · HCl can be employed as a manufacturing intermediate for peptide-based and peptidomimetic chemistries that require protected amino acid inputs with acid-labile carboxyl protection. The tert-butyl ester enables controlled conversion between protected and deprotected states, supporting route design where intermediate isolation and purification benefit from a stable ester form. The hydrochloride salt provides a predictable amine salt handling profile, which can be advantageous for feeding into coupling or activation steps in industrial fine chemical synthesis. The norvaline side chain contributes a defined hydrophobic segment that is commonly relevant to peptide fragment generation, enabling downstream formation of amide-linked intermediates used in larger synthetic sequences.
4. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.